Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-16

Clinical Trial Update: Observational Study of the EnligHTN Renal Denervation System in Europe

View source ↗

Summary

An observational study of the EnligHTN renal denervation system in Europe has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EnligHTN Renal Denervation System (renal denervation catheter system)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Uncontrolled Hypertension | Status: COMPLETED | Results posted: 2019-10-16